Articles From: LIONSGATE TO RELEASE FISCAL YEAR 2014 SECOND QUARTER EARNINGS AND TO HOLD ANALYST AND INVESTOR CONFERENCE CALL PREMARKET ON FRIDAY, NOVEMBER 8, 2013 to LipoScience to Present at 25th Annual Piper Jaffray Healthcare Conference


2013/10/30
LIONSGATE TO RELEASE FISCAL YEAR 2014 SECOND QUARTER EARNINGS AND TO HOLD ANALYST AND INVESTOR CONFERENCE CALL PREMARKET ON FRIDAY, NOVEMBER 8, 2013 Canada NewsWire SANTA MONICA, Calif.
Sign-up for LIONSGATE TO RELEASE FISCAL YEAR 2014 SECOND QUARTER EARNINGS AND TO HOLD ANALYST AND INVESTOR CONFERENCE CALL PREMARKET ON FRIDAY, NOVEMBER 8, 2013 investment picks
2014/1/16
LIONSGATE TO RELEASE FISCAL YEAR 2014 THIRD QUARTER EARNINGS AFTER MARKET CLOSE ON THURSDAY, FEBRUARY 6, 2014 AND TO HOLD ANALYST AND INVESTOR CONFERENCE CALL ON FRIDAY, FEBRUARY 7, 2014 Canada NewsWire SANTA MONICA, Calif.
Sign-up for LIONSGATE TO RELEASE FISCAL YEAR 2014 THIRD QUARTER EARNINGS AFTER MARKET CLOSE ON THURSDAY, FEBRUARY 6, 2014 AND TO HOLD ANALYST AND INVESTOR CONFERENCE CALL ON FRIDAY, FEBRUARY 7, 2014 investment picks
Announcement Starts 100-Day Countdown to Film's Release in Theatres Around The World on November 22 SANTA MONICA, Calif.
Sign-up for LIONSGATE TO UNVEIL THE HUNGER GAMES: CATCHING FIRE WITH WORLD PREMIERE IN LONDON ON NOVEMBER 11, 2013 investment picks
LIONSGATE TO UNVEIL THE HUNGER GAMES: CATCHING FIRE WITH WORLD PREMIERE IN LONDON ON NOVEMBER 11, 2013 Canada NewsWire Announcement Starts 100-Day Countdown to Film's Release in Theatres Around The World on November 22 SANTA MONICA, Calif.
Sign-up for LIONSGATE TO UNVEIL THE HUNGER GAMES: CATCHING FIRE WITH WORLD PREMIERE IN LONDON ON NOVEMBER 11, 2013 investment picks
LIONSGATE'S THE HUNGER GAMES: CATCHING FIRE APPROVED FOR NOVEMBER 21, 2013 RELEASE IN CHINA Canada NewsWire Will Be Released On More Than 3,000 Chinese Screens Nationwide SANTA MONICA, Calif.
Sign-up for LIONSGATE'S THE HUNGER GAMES: CATCHING FIRE APPROVED FOR NOVEMBER 21, 2013 RELEASE IN CHINA investment picks
2013/10/22
Will Be Released On More Than 3,000 Chinese Screens Nationwide SANTA MONICA, Calif.
Sign-up for LIONSGATE'S THE HUNGER GAMES: CATCHING FIRE APPROVED FOR NOVEMBER 21, 2013 RELEASE IN CHINA investment picks
2014/1/7
SALT LAKE CITY, Jan.
Sign-up for Lipocine Announces New Appointments to Its Board of Directors investment picks
Lipocine Inc. ( OTCQB/OTCBB :LPCN), a specialty pharmaceutical company, announced today that it has changed its trading symbol from OTCBB:MBARD to OTCQB/OTCBB:LPCN. On July 24, 2013, Lipocine successfully completed a reverse merger with Marathon Bar Corp.
Sign-up for Lipocine Inc. Announces Change in Trading Symbol investment picks
Lipocine, Inc. (OTCBB:MBARD) , a specialty pharmaceutical company, announced today that it has closed its previously announced private placement with institutional investors.
Sign-up for Lipocine Inc. Announces Closing of $38 Million Private Placement to Advance Its Oral Testosterone Product Portfolio investment picks
SALT LAKE CITY, Dec.
Sign-up for Lipocine Inc. Announces Exercise and Closing of Over-Allotment Option investment picks
2013/11/27
SALT LAKE CITY, Nov.
Sign-up for Lipocine Inc. Announces Pricing of Public Offering of Common Stock investment picks
2013/9/16
Lipocine Inc. (“Lipocine”) ( OTCQB/OTCBB : LPCN), a specialty pharmaceutical company, announced today that Morgan Brown has joined the Company as Executive Vice President and Chief Financial Officer (“CFO”). Mr.
Sign-up for Lipocine Inc. Appoints Morgan Brown as Executive Vice President and Chief Financial Officer investment picks
2014/3/10
RALEIGH, N.C., March 10, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) , a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2013.
Sign-up for LipoScience Announces 2013 Fourth Quarter and Full Year Financial Results investment picks
2013/11/25
RALEIGH, N.C. , Nov.
Sign-up for LipoScience Announces Agreement With Scripps Health For First California Placement Of Vantera® Clinical Analyzer investment picks
2014/1/22
RALEIGH, N.C., Jan.
Sign-up for LipoScience Announces Appointment of Howard Doran as President and Chief Executive Officer investment picks
2013/8/9
RALEIGH, N.C. , Aug.
Sign-up for LipoScience Announces Appointment Of Vice President, General Counsel And Corporate Secretary investment picks
RALEIGH, N.C. , Sept.
Sign-up for LipoScience Announces Appointment Of William Cromwell, M.D., As Chief Medical Officer investment picks
2013/9/4
JUPITER study data published in Circulation, suggest HDL-P may be a better marker of residual risk than HDL cholesterol or apolipoprotein A-1 in patients on statin therapy RALEIGH, N.C. , Sept.
Sign-up for LipoScience Announces New Data Supporting High-Density Lipoprotein Particle (HDL-P) Number As Marker Of Cardiovascular Risk investment picks
2014/3/28
RALEIGH, N.C., March 28, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced the termination of its relationship with Health Diagnostics Laboratory, Inc. ("HDL Inc."), one of its laboratory customers.
Sign-up for LipoScience Announces Termination of Contract With Health Diagnostics Laboratory investment picks
RALEIGH, N.C., Aug.
Sign-up for LipoScience Announces Two New Members of Board of Directors investment picks
2013/8/2
Company Reports Preliminary Revenues for Second Quarter in Line With Previous Guidance Company Revises Revenue Guidance for Calendar Year 2013 to Between $52 and $54 Million RALEIGH, N.C., Aug, 2, 2013 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) , a diagnostic company pioneering a new field of personalized NMR diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, announced today that Richard Brajer has stepped down as President, CEO and Director to pursue other interests.
Sign-up for LipoScience Appoints Robert Greczyn Interim President and Chief Executive Officer investment picks
2013/8/6
Second Quarter 2013 NMR LipoProfile® Test Volumes Up 7.5% from 2012 Period RALEIGH, N.C., Aug.
Sign-up for LipoScience Reports Second Quarter 2013 Financial Results investment picks
2013/11/5
Third Quarter 2013 NMR LipoProfile® Test Volumes Up 3.8% from 2012 Period RALEIGH, N.C., Nov.
Sign-up for LipoScience Reports Third Quarter 2013 Financial Results investment picks
Posters Presented at American Association of Clinical Chemistry (AACC) Meeting Highlight Utility of NMR Technology in Inflammatory Disease Risk Assessment and Diagnosis of Diabetes RALEIGH, N.C. , July 31, 2013 /PRNewswire/ -- Researchers from LipoScience, Inc. (NASDAQ: LPDX) , a diagnostic company pioneering a new field of personalized NMR diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, are presenting two posters today that highlight the utility of the company's proprietary nuclear magnetic resonance (NMR) technology in measuring novel markers of systemic inflammation, as well as in diagnosing diabetes through measurement of blood glucose.
Sign-up for LipoScience Research Sheds Light On Novel Markers Via Nuclear Magnetic Resonance (NMR) Spectroscopy investment picks
RALEIGH, N.C., Nov.
Sign-up for LipoScience to Present at 25th Annual Piper Jaffray Healthcare Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: LIONSGATE TO RELEASE FISCAL YEAR 2014 SECOND QUARTER EARNINGS AND TO HOLD ANALYST AND INVESTOR CONFERENCE CALL PREMARKET ON FRIDAY, NOVEMBER 8, 2013 to LipoScience to Present at 25th Annual Piper Jaffray Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity